SCHEMBL6238059

SCHEMBL6238059

Cc1cccc2nc(-c3ccco3)c(-c3ccco3)nc12

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.62
TDP1 Q9NUW8 6/20 0.62
MEN1 O00255 6/20 0.62
KMT2A Q03164 6/20 0.62
ALDH1A1 P00352 5/20 0.62
POLB P06746 5/20 0.62
BLM P54132 5/20 0.62
KDM4E B2RXH2 4/20 0.62
HPGD P15428 4/20 0.62
PTPN7 P35236 4/20 0.62
RECQL P46063 4/20 0.62
ALOX15 P16050 3/20 0.62
HSD17B10 Q99714 3/20 0.62
L3MBTL1 Q9Y468 3/20 0.62
PKM P14618 2/20 0.62
CASP1 P29466 2/20 0.62
CASP7 P55210 2/20 0.62
TSHR P16473 2/20 0.62
THRB P10828 3/20 0.55
ALOX12 P18054 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28079538 0.91 MEN1 (0.57) MAPTTDP1MEN1KMT2AALDH1A1
SCHEMBL27734202 0.78 MEN1 (1.00) MAPTTDP1MEN1KMT2AALDH1A1
SCHEMBL8006645 0.74 ALDH1A1 (0.75) MAPTTDP1MEN1KMT2AALDH1A1
SCHEMBL28532446 0.73 TDP1 (0.62) MAPTTDP1MEN1KMT2AALDH1A1
SCHEMBL20475325 0.73 RAB9A (0.53) MAPTMEN1KMT2AALDH1A1POLB
SCHEMBL31643056 0.73 RAB9A (0.53) MAPTMEN1KMT2AALDH1A1POLB
SCHEMBL2114343 0.73 MAPT (1.00) MAPTTDP1MEN1KMT2AALDH1A1
SCHEMBL12578244 0.72 MAPT (0.58) MAPTTDP1MEN1KMT2AALDH1A1
SCHEMBL6238182 0.71 PIK3R1 (0.66) MAPTTDP1MEN1KMT2AALDH1A1
SCHEMBL28079386 0.70 MEN1 (0.81) MAPTTDP1MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005007099-A2 PKB INHIBITORS AS ANTI-TUMOR AGENTS IMCLONE SYSTEMS INCORPORATED (US) 2005-01-27 WO disclosed